Healthcare

Vocal Cord Paralysis Treatment Market

By Segment, By Region, And Segment Forecasts, 2015 – 2023

Vertical: HealthcareBase Year: 201712 Sections

Executive Summary

Vocal Cord Paralysis Treatment Market — Snapshot

  • Market Size (2015)

    2015

    $2.16B

  • Projected (2023)

    2023

    $2.92B

  • CAGR (2015–2023)

    3.8%

    3.8%
  • Key Players

    108+

Vocal cord paralysis is caused by the disruption of nerve impulses to the muscles of the larynx or voice box. Vocal cord paralysis may be caused by injury to the head, neck, or chest; lung or thyroid cancer; tumors of the neck or chest; or infection. The nerves controlling the vocal cords are long and can be vulnerable to injury in parts of the body, not usually associated with the vocal cords. The factors that are anticipated to propel the growth of the global vocal cord paralysis treatment market include the growing occurrences of the causes of vocal cord paralysis, technological advancements in the medical field, and rising healthcare expenditure. However, the high cost associated with the treatments may hinder the growth of the market during the forecast period.

The global vocal cord paralysis treatment market is expected to reach USD 2920.2 million by 2023 from USD 2334.7 million in 2017 and is expected to register a CAGR of 3.8% during the forecast period from 2018 to 2023. In 2017, the market was led by the Americas with 35.4% share, followed by Europe and Asia-Pacific with shares of 32.4% and 23.5%, respectively.

The global vocal cord paralysis treatment market has been segmented based on type, treatment, and region.

On the basis of type, Unilateral accounted for the largest market share of 89.3% in 2017, with a market value of USD 2145.1 million, which is projected to register a CAGR of 3.6% during the forecast period.

Based on treatment, voice therapy accounted for the largest market share of 62.8% in 2017, with a market value of USD 1508.7 million, which is projected to register a CAGR of 3.4%.

Key Insight

The Vocal Cord Paralysis Treatment Market market is projected to grow at a CAGR of 3.8% from 2015 to 2023.

Market Performance Trend

Historical performance and future projections (2020–2030, USD Billion)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Scope & Coverage

What this report covers

  • Geographic Coverage: This analysis covers 5 regions: Middle East and Africa, North America, Asia Pacific, Europe, South America.
  • Market Segmentation: The market is analyzed across 2 segments: Unilateral, Bilateral. Forecasts are provided for each segment from 2015 to 2023.
  • Competitive Landscape: 108 leading companies are profiled, covering market positioning, strategies, and recent developments.

Market Size (USD Mn)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Overview

Vocal Cord Paralysis Treatment Market — Growth Trajectory

Vocal cord paralysis is a condition caused when the nerves going to the vocal cord are damaged leading to the interruption of nerve impulses in the larynx or the voice box. In other terms, vocal cord paralysis occurs when one or both the vocal cords do not function properly.

Vocal Cord Paralysis Treatment Market — Growth Trajectory

Unilateral
Bilateral

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Size Trend (USD Mn)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Market Dimensions

How this market is segmented

  • Type Type is broken down into: Unilateral, Bilateral.
  • Treatment Treatment is broken down into: Voice Therapy, Surgery.
  • Vocal Cord Paralysis Treatment_Surgery Vocal Cord Paralysis Treatment_Surgery is broken down into: Structural implants, Bulk Injection, Vocal cord repositioning (Phonosurgery), Tracheotomy, Surgery_Others.

Geographic Analysis

Regional market breakdown

  • Middle East and Africa Middle East and Africa market size reached $188.65M in 2015 and is projected to reach $257.15M by 2023, growing at a CAGR of 3.9%.
  • North America North America market size reached $580.93M in 2015 and is projected to reach $772.92M by 2023, growing at a CAGR of 3.6%.
  • Asia Pacific Asia Pacific market size reached $503.61M in 2015 and is projected to reach $697.42M by 2023, growing at a CAGR of 4.2%.
  • Europe Europe market size reached $697.38M in 2015 and is projected to reach $958.15M by 2023, growing at a CAGR of 4.1%.
  • South America South America market size reached $192.18M in 2015 and is projected to reach $234.61M by 2023, growing at a CAGR of 2.5%.

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Research Methodology

Vocal Cord Paralysis Treatment Market — How We Researched This Market

This report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.

  • Base Year

    2017

  • Historical Period

    2015 – 2017

  • Forecast Period

    2017 – 2023

  • Primary Interviews

    150+

Research Process

Historical data (2015–2017) and forecast period (2017–2023)

1

Problem Definition

  • Market scoping
  • Objective setting
  • Framework design
2

Secondary Research

  • Literature review
  • Data mining
  • Trend analysis
3

Primary Research

  • Expert interviews
  • Field visits
  • Surveys
4

Data Analysis

  • Quantitative modeling
  • Statistical testing
  • Validation
5

Insights & Reporting

  • Synthesis
  • Recommendations
  • Visualization

Research Depth

Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.

Historical vs. Forecast Data

Historical (observed)
Forecast (modelled)

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Competitive Landscape & Porter's Five Forces

Vocal Cord Paralysis Treatment Market — Competitive Analysis

Bargaining Power of Suppliers

Bargaining power of suppliers in the vocal cord paralysis treatment market is medium. Currently, the market consists of a limited number of players. However, few existing key companies capture significant share in the market and have the capability of fluctuating the costs of the products used for diagnosis and treatment of vocal cord disease. The overall bargaining power of suppliers in the global vocal cord paralysis treatment market is medium.

Bargaining Power of Buyers

The bargaining power of buyers is medium in the global vocal cord paralysis treatment market. The presence of buyers in the market is rising, as the prevalence of vocal cord paralysis, and related causative factors are growing steadily. In addition, buyers are price sensitive, which moderately affects their bargaining power in the market. The market is characterized by a low availability of substitute product which reduces the buying power in the industry.

Threat of New Entrants

The threat of new entrants in the global vocal cord paralysis treatment market is medium. Any company trying to enter the market is required to accept the mandatory regulatory standards issued by government authorities. The market is also characterized by a high degree of brand loyalty where establishing a brand name is difficult for newcomers. Furthermore, the cost involved in research and development (R&D) is comparatively high which does not comfort the new entrants to enter the market easily.

Threat of Substitutes

The threat of substitutes in the global vocal cord paralysis treatment market is low to medium. There are very less substitutes available in the market, and buyer propensity to substitute is low. So, quality and trust issue and excellent service provided by the existing players restrict the threat by the substitutes.

Intense Rivalry

The degree of competition in the global vocal cord paralysis treatment market is low to medium. The moderate degree of product differentiation among existing players increases the intensity of rivalry in the market. Companies involved in vocal cord paralysis treatment market are trying to introduce more advanced diagnostic equipment, for differentiating their product from their rivals. Additionally, very few companies are focused on the development of treatment options for vocal cord paralysis which further adds to the fewer chances of rivalry in the market.

Quantitative Analysis

Regional Breakdown

Regional market breakdown for Vocal Cord Paralysis Treatment Market.

Regional Market Size (USD Mn)

Market estimates by geography (2023)

USD Mn

InsightEurope leads with $958.15M by 2023, while Asia Pacific is projected to grow fastest at a 4.2% CAGR.

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Regional Market Data

REGION201520172023CAGRSHARE
Middle East and Africa$188.65M$220.63M$257.15M3.9%9%
North America$580.93M$671.62M$772.92M3.6%26%
Asia Pacific$503.61M$593.61M$697.42M4.2%24%
Europe$697.38M$818.79M$958.15M4.1%33%
South America$192.18M$210.89M$234.61M2.5%8%
Total$2.16B$2.52B$2.92B3.8%100%

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans

Segment Revenue (2023)

Unilateral
Bilateral
0728145621842912

Segment Market Share

  • Unilateral89%
  • Bilateral11%

Total Market Size

$2.97B

Market by Segment (2023)

APPLICATIONREVENUE ($B)GROWTH RATEMARKET PENETRATION
Unilateral$2.65B3.8%
67%
Bilateral$323.11M3.8%
60%

* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.

Subscribe to Wantstats

Unlock premium reports, insights, blogs, charts and more.

View Subscription Plans
Empower your Business
with Insights

Save over 20% on
Annual Subscription

See plans for professionals or small and medium businesses.

Wantstats analytics dashboard

Analytics

Vocal Cord Paralysis Treatment Market — Key Findings

Analytical insights on Vocal Cord Paralysis Treatment Market covering market dynamics, competitive landscape, and strategic outlook.

Key Analytical Findings

The Vocal Cord Paralysis Treatment Market market is projected to reach $2.92B by 2023, growing at 3.8% CAGR. The Unilateral segment holds the largest share.

Market Dynamics

Vocal cord paralysis is the common congenital defect of the voice box or larynx. Vocal cord paralysis or vocal fold paralysis is an inability of one or both vocal cords to move properly. It results from the abnormal nerve input to laryngeal muscles. Factors such as technological advancements, increasing prevalence of causing factors of voice cord paralysis, and growing healthcare expenditure are expected to drive the growth of the market during the forecast period. However, high cost associated with the treatment of vocal cord paralysis may restrain the market growth during the forecast period.

Market Drivers

The etiological factors causing vocal cord paralysis include accidental brain trauma, surgeries, and neoplasm, among others. Surgeries that carry a risk of vocal cord paralysis include surgeries to the thyroid or parathyroid glands, esophagus, neck, and chest. The rising prevalence of brain and neck injuries increase the chances of damage to the vocal cord. According to the Centers for Disease Control and Prevention (CDC) in 2014, approximately 2.5 million people sustain a traumatic brain injury annually in the US. Moreover, the growing occurrences of head, neck, and larynx cancers are expected to significantly contribute to the growth of the market. According to the American Cancer Society, the estimated number of new cancer cases involving larynx was 13,360 in the US for the year 2017. As per the Australian Institute of Health and Welfare, an estimated 4,956 new cases of head and neck cancer were diagnosed in 2017 in Australia. According to an article published in the National Center for Biotechnology Information (NCBI) in 2015, the average rate of temporary vocal cord paralysis was 9.8%, whereas the average rate of permanent vocal cord paralysis was 2.3%.

Market Opportunities

The growing availability of funding and reimbursement for certain vocal cord paralysis treatments in developed countries such as the US can be a huge opportunity for the market during the assessment period. Medicare and some private insurers provide reimbursement to hospitals for patients undergoing tracheostomy procedures. Moreover, according to the data mentioned in The American Laryngological Rhinological and Otological Society, Inc. in 2015, about 72% reimbursement for endoscopy suite (ES) hospital injection laryngoplasty and 31% for operating room (OR) injection laryngoplasty are available in the US.

Market Restraints

The increasing occurrences of vocal cord dysfunction have led to the development of various treatment options; however, the costs of these treatments are generally high. The high cost associated with the treatment of vocal cord paralysis is hampering the growth of the market. The average cost of injection laryngoplasty is USD 698.65 per patient. In one recent report by the National Institutes of Health, the average hospital charges were about USD 123,000 with a percutaneous tracheostomy and about USD 156,000 with an open tracheostomy. In addition to this, the cost of vocal fold medialization was about USD 2,200 in 2017.

Strategic Outlook and Future Directions

Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.

Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.

Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.

Market Value by Segment (2023)

Value (USD Mn)
Unilateral
Bilateral

Companies

Key companies profiled in Vocal Cord Paralysis Treatment Market

Profiles of 108 companies operating in the Vocal Cord Paralysis Treatment Market market, including revenue, employee count, and market positioning where available.

Showing 108 of 108 companies

Olympus Co

Olympus Corporation

Healthcare

Company Headquarters: Japan Founded: 1919 Workforce: 46,500 Company Working: Olympus Corporation is a Japanese multinational corporation that specializes in manufacturing and selling optical and reprography products, as well as medical and surgical equipment. The company was founded in 1919 and is headquartered in Tokyo, Japan. Olympus Corporation is organized into four main business segments: Medical, Scientific Solutions, Imaging, and Financial. The Medical segment is the largest and most important business segment of the company, accounting for approximately two-thirds of the company's total revenue. The Medical segment includes endoscopy and surgical products, as well as clinical and research microscopes which includes Biopsy devices. Within the Medical segment, Olympus Corporation offers a range of products for minimally invasive surgical procedures, including endoscopes and endotherapy devices. One of the key products offered by Olympus Corporation is its biopsy device, which is used to collect tissue samples from various parts of the body for diagnostic purposes. Olympus Corporation's biopsy device is designed to be used with endoscopes and comes in a range of sizes and shapes to suit different clinical needs. The company has a global presence with operations in various regions around the world. The company's headquarters is located in Tokyo, Japan, and it has several subsidiaries and offices in different countries.

Revenue$7.3B
Employees46,500
Market CapN/A
Founded1918
Japan
FUJIFILM H

FUJIFILM Holdings Corporation

Healthcare

Company Headquarter: Minato, Tokyo, Japan Founded: 1934 Workforce: 77,739 Employees (2017) Company Working: FUJIFILM Holdings Corporation company is engaged in developing, manufacturing, and marketing the imaging, information, and document solutions. Its product portfolio includes color films, digital cameras, photofinishing products, and equipment. The company manufactures medical equipment, optical devices, and provides services for office copy machines, printers, and related equipment.

Revenue$19.8B
Employees77,739
Market CapN/A
Founded1933
United States, North America
Therapy So

Therapy Solutions Inc

Healthcare

Company Headquarter: Narberth, Pennsylvania, US Company Working: The company provides comprehensive therapeutic services for a wide range of developmental delays, speech-language therapy, physical therapy, and occupational therapy along with educational and psychological services. Moreover, the company also offers private office-based speech therapy services.

RevenueN/A
EmployeesN/A
Market CapN/A
FoundedN/A
United States, North America
LifeCell C

LifeCell Corporation

Healthcare

LifeCell Corporation is a regenerative medicine company engaged in developing and marketing tissue repair products for reconstructive, urogynecologic, and orthopedic surgical procedures. As of February 1, 2017, the company operated as a subsidiary of Allergan plc. As the company is the subsidiary of Allergan Plc, hence, financials of Allergen Plc are mentioned.

Revenue$12.7B
EmployeesN/A
Market CapN/A
FoundedN/A
United States, North America
Smiths Gro

Smiths Group

Healthcare

Company Headquarter: London, UK Founded: 1851 Workforce: 7700 Employees (2017) Company Working: Smiths Group plc designs, manufactures, and sells a broad range of products and services globally. The medical division of the company provides specialty medical devices and consumables, including infusion systems, vascular access, temperature management equipment, and specialty devices in areas of diagnostics and emergency patient transport. The company has its presence in over 120 countries.

Revenue$0.9B
Employees7,700
Market CapN/A
Founded1850
United States, North America
Teleflex I

Teleflex Incorporated

Healthcare

Company Headquarter: Wayne, Pennsylvania, US Founded: 1981 Workforce: 14,000+ Employees (2017) Company Working: Teleflex Incorporated is engaged in designing, developing, manufacturing, and supplying single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications globally. Its vascular access product portfolio comprises arrow branded catheters and related devices, including catheter positioning systems for use in the administration of intravenous medications and other therapies, and devices for treating coronary and peripheral vascular disease. Moreover, the company serves hospitals and healthcare providers, medical device manufacturers, and home care markets.

Revenue$2.6B
Employees14,000
Market CapN/A
Founded1980
United States, North America
Page 1 of 18
Go to page

About the Author

Healthcare Research Team

Healthcare

Our healthcare desk at Wantstats is staffed by a mix of clinical-market analysts and a senior researcher who track drug approvals, device launches, and provider economics as they happen — not just at reporting time. Every figure in this report is checked against primary interviews, regulatory filings, and our own proprietary datasets before it goes to print.

Powering the world's best teams.
From next-gen startups to established enterprises.

Google logo
Amazon logo
Microsoft logo
Intel logo
Neste logo
McKinsey & Company logo
Deloitte logo
Accenture logo
Oracle logo
PWC logo
EY logo
Honeywell logo

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri
Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Noah Malgeri
Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

Vocal Cord Paralysis Treatment Market

Starting from
$4,950